SUN PHARMA SHARE PRICE
Buy Aurobindo Pharma, price target Rs 515: Manas Jaiswal
The analyst suggested a stoploss at Rs 484.
Sell Aurobindo Pharma, price target Rs 460: Kunal Bothra
The analyst suggested a stoploss at Rs 492 .
Promoters raising stake in these midcaps, should you buy too?
Increases in promoter equity are generally considered to point to ‘good times’ ...
Sensex jumps 200 points, trades at all-time high; Nifty tops 12,400
Shares of oil exploration and marketing companies were down as oil prices jumped.
Key driver of D-Street picked top IT, infra, metals, pharma names in Q3
The insurance behemoth offloaded some shares of telecom, power, oil retailers and hospitals.
Rise in gold prices will aid recovery in rural areas: Pankaj Tibrewal, Kotak Mutual Fund
"Since Oct we are seeing the breadth being better and month to date the smallcap index is up 5%."
Buy AstraZeneca Pharma, price target Rs 2,700: Jayesh Bhanushali
The analyst suggested a stoploss at Rs 2500.
Sun, Aurobindo and Dr Reddy’s are CLSA’s top picks in pharma
Here’s what CLSA is saying about its best ideas for 2020 in the pharma space.
Investors can expect returns of 8-9% from Nifty this year: Mahesh Patil
Largecaps will continue to do well, mid and smallcap companies could catch up, says Patil.
Stocks in the news: Gati, Bharti Airtel, Alembic Pharma, Aster DM and DHFL
GMR Infra has raised Rs 2,000 crore debt through nonconvertible debentures from Tata Sons.
Stocks in the news: YES Bank, NBCC, BPCL, HCC, RIL, ZEEL and Sun Pharma
CLSA has retained buy rating on Zee Entertainment Enterprises and revised target price to Rs 360 from Rs 390.
Market Movers: IndusInd sinks 5%, YES rallies; 100 stocks 'overbought'
The broader market was upbeat, as Nifty Midcap and Nifty Smallcap indices gained 1% each.
Global interest rate fall is permanent; it will lead to asset price inflation: Big Bull
In an interview with ETNOW, the Big Bull shared his views on how he expects the market to shape up.
In market carnage, look to buy in IT and select pharma pockets: Yogesh Mehta
These are names where the correction is very minor today.
Sensex sheds 190 points, Nifty tests 12,300 ahead of signing of US-China trade deal
Nifty Smallcap down 0.13 per cent and Nifty Midcap down 0.03 per cent.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service